723 related articles for article (PubMed ID: 22740590)
41. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
[TBL] [Abstract][Full Text] [Related]
43. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
[TBL] [Abstract][Full Text] [Related]
44. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
[TBL] [Abstract][Full Text] [Related]
45. Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid.
Hayette MP; Vaira D; Susin F; Boland P; Christiaens G; Melin P; De Mol P
J Clin Microbiol; 2001 Jun; 39(6):2338-40. PubMed ID: 11376086
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
[TBL] [Abstract][Full Text] [Related]
47. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
Eigl S; Prattes J; Reinwald M; Thornton CR; Reischies F; Spiess B; Neumeister P; Zollner-Schwetz I; Raggam RB; Flick H; Buchheidt D; Krause R; Hoenigl M
Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363
[TBL] [Abstract][Full Text] [Related]
48. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
[TBL] [Abstract][Full Text] [Related]
49. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
50. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
[TBL] [Abstract][Full Text] [Related]
51. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
Verweij PE; Latgé JP; Rijs AJ; Melchers WJ; De Pauw BE; Hoogkamp-Korstanje JA; Meis JF
J Clin Microbiol; 1995 Dec; 33(12):3150-3. PubMed ID: 8586691
[TBL] [Abstract][Full Text] [Related]
52. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
Hoenigl M; Strenger V; Buzina W; Valentin T; Koidl C; Wölfler A; Seeber K; Valentin A; Strohmeier AT; Zollner-Schwetz I; Raggam RB; Urban C; Lass-Flörl C; Linkesch W; Krause R
J Antimicrob Chemother; 2012 Aug; 67(8):2029-33. PubMed ID: 22566591
[TBL] [Abstract][Full Text] [Related]
53. Use of mycological, nested PCR, and real-time PCR methods on BAL fluids for detection of Aspergillus fumigatus and A. flavus in solid organ transplant recipients.
Zarrinfar H; Mirhendi H; Makimura K; Satoh K; Khodadadi H; Paknejad O
Mycopathologia; 2013 Dec; 176(5-6):377-85. PubMed ID: 24045934
[TBL] [Abstract][Full Text] [Related]
54. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.
Husain S; Paterson DL; Studer SM; Crespo M; Pilewski J; Durkin M; Wheat JL; Johnson B; McLaughlin L; Bentsen C; McCurry KR; Singh N
Transplantation; 2007 May; 83(10):1330-6. PubMed ID: 17519782
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of Commercially Available Real-Time Polymerase Chain Reaction Assays for the Diagnosis of Invasive Aspergillosis in Patients with Haematological Malignancies.
Erman-Daloglu A; Ozhak B; Salim O; Turhan O; Ongut G; Gunseren F; Colak D; Ogunc D
Mycopathologia; 2020 Apr; 185(2):269-277. PubMed ID: 31950340
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance.
Fréalle E; Decrucq K; Botterel F; Bouchindhomme B; Camus D; Dei-Cas E; Costa JM; Yakoub-Agha I; Bretagne S; Delhaes L
Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):223-32. PubMed ID: 18763000
[TBL] [Abstract][Full Text] [Related]
57. Molecular detection of invasive aspergillosis in hematologic malignancies.
Badiee P; Kordbacheh P; Alborzi A; Ramzi M; Shakiba E
Infection; 2008 Dec; 36(6):580-4. PubMed ID: 18854937
[TBL] [Abstract][Full Text] [Related]
58. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
[TBL] [Abstract][Full Text] [Related]
59. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Khot PD; Ko DL; Hackman RC; Fredricks DN
BMC Infect Dis; 2008 May; 8():73. PubMed ID: 18510764
[TBL] [Abstract][Full Text] [Related]
60. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
Danylo A; Courtemanche C; Pelletier R; Boudreault AA
Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
